Citation Impact
Citing Papers
A Logic-Gated Nanorobot for Targeted Transport of Molecular Payloads
2012 StandoutScience
Function and Structure of a Prokaryotic Formylglycine-generating Enzyme
2008 StandoutNobel
High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.
2001
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
Introduction of a Disulfide Bond into a Cationic Lipid Enhances Transgene Expression of Plasmid DNA
1998
Improving the efficacy of antibody-based cancer therapies
2001
Protein‐Based Nanomedicine Platforms for Drug Delivery
2009
Mesoporous silica nanoparticles in biomedical applications
2012 StandoutNobel
Drug targeting with nano-sized carrier systems
2005
Prodrug Strategies in Anticancer Chemotherapy
2007
Linker Technologies for Antibody–Drug Conjugates
2013
Biocompatible Carbon Nanotubes Generated by Functionalization with Glycodendrimers
2008 StandoutNobel
Rationally Designed Chemical Modulators Convert a Bacterial Channel Protein into a pH‐Sensory Valve
2006 StandoutNobel
Chemoselective ligation reactions with proteins, oligosaccharides and cells
1998
CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
2019 StandoutNobel
Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates
2014
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Polymeric anticancer drugs with pH-controlled activation
2004
Molecular Assembly of an Aptamer–Drug Conjugate for Targeted Drug Delivery to Tumor Cells
2009
Site-specific antibody drug conjugates for cancer therapy
2013
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
Polymeric micelles for drug targeting
2007
The Design of Cationic Lipids for Gene Delivery
2005
Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration
2011 StandoutNobel
Site-specific Conjugation on Serine → Cysteine Variant Monoclonal Antibodies
2000
GlcNAc 2-Epimerase Can Serve a Catabolic Role in Sialic Acid Metabolism
2003 StandoutNobel
Programmable Cell Adhesion Encoded by DNA Hybridization
2005 StandoutNobel
A Bioorthogonal Reaction of N‐Oxide and Boron Reagents
2015 StandoutNobel
Site-directed conjugation of nonpeptide groups to peptides and proteins via periodate oxidation of a 2-amino alcohol. Application to modification at N-terminal serine
1992
Tumor-activated Prodrugs—A New Approach to Cancer Therapy
2004
Glycocalyx Engineering with a Recycling Glycopolymer that Increases Cell Survival In Vivo
2015 StandoutNobel
“Cascade‐Release Dendrimers” Liberate All End Groups upon a Single Triggering Event in the Dendritic Core
2003
Designing dendrimers for biological applications
2005 Standout
Kinetic parameters for small-molecule drug delivery by covalent cell surface targeting
2001 StandoutNobel
Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities
2003
Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapy
2014
Arming antibodies: prospects and challenges for immunoconjugates
2005
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
2003
Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate
2004
Peptide conjugation to an in vitro-selected DNA ligand improves enzyme inhibition.
1995
Hierarchical Assembly of Model Cell Surfaces: Synthesis of Mucin Mimetic Polymers and Their Display on Supported Bilayers
2007 StandoutNobel
Polyester Dendritic Systems for Drug Delivery Applications: Design, Synthesis, and Characterization
2002
Sortase-mediated modification of αDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes
2013
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
2016 Standout
Functional Nucleic Acid Sensors
2009 Standout
Supramolecular Coordination: Self-Assembly of Finite Two- and Three-Dimensional Ensembles
2011 Standout
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
Scalable and Highly Diastereo- and Enantioselective Catalytic Diels–Alder Reaction of α,β-Unsaturated Methyl Esters
2018 StandoutNobel
Asymmetrische induktion bei diels-alder-reaktionen
1966
A New Strategy for the Site-Specific Modification of Proteins in Vivo
2003
Methods for site-specific drug conjugation to antibodies
2013
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Nonviral Vectors for Gene Delivery
2008 Standout
Uptake and Metabolism of a Dual Fluorochrome Tat-nanoparticle in HeLa Cells
2003
Advances in targeted therapeutic agents
2010
Synthesis and Activity of Ruthenium Alkylidene Complexes Coordinated with Phosphine and N-Heterocyclic Carbene Ligands
2003 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Randomized Phase II Study of BR96-Doxorubicin Conjugate in Patients With Metastatic Breast Cancer
1999
Preparation of alumina supported copper nanoparticles and their application in the synthesis of 1,2,3-triazoles
2006
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Reduction−Alkylation Strategies for the Modification of Specific Monoclonal Antibody Disulfides
2005
Memory Effects and Stereochemistry in Multiple Carbonium Ion Rearrangements
1968
Coordinative alignment of molecules in chiral metal-organic frameworks
2016 StandoutScienceNobel
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
1998
A Pictet-Spengler ligation for protein chemical modification
2012 StandoutNobel
Bridging Disulfides for Stable and Defined Antibody Drug Conjugates
2014
Plasmons in Strongly Coupled Metallic Nanostructures
2011 Standout
Chemoselective Elaboration of O-Linked Glycopeptide Mimetics by Alkylation of 3-ThioGalNAc
2001 StandoutNobel
Bioconjugation by Copper(I)-Catalyzed Azide-Alkyne [3 + 2] Cycloaddition
2003 StandoutNobel
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
2011 Standout
Tailor-Made Dual pH-Sensitive Polymer–Doxorubicin Nanoparticles for Efficient Anticancer Drug Delivery
2011
A biomimic pH-sensitive polymeric prodrug based on polycarbonate for intracellular drug delivery
2013
Enzyme-Responsive Snap-Top Covered Silica Nanocontainers
2008 StandoutNobel
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
2001
Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development
2014 StandoutNobel
Development of orally active inhibitors of protein and cellular fucosylation
2013
Poly (γ-glutamic acid) based combination of water-insoluble paclitaxel and TLR7 agonist for chemo-immunotherapy
2014
Polyester Dendritic Systems for Drug Delivery Applications: In Vitro and In Vivo Evaluation
2002
Imaging Cell Surface Glycans with Bioorthogonal Chemical Reporters
2007 StandoutNobel
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Metal–Organic Frameworks in Biomedicine
2011 Standout
Stereoselective hydrogenation via dynamic kinetic resolution
1989 StandoutNobel
Cu-Catalyzed Azide−Alkyne Cycloaddition
2008 StandoutNobel
The absolute configuration of methyl jasmonate
1965
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
A cell nanoinjector based on carbon nanotubes
2007 StandoutNobel
Synthesis of Lipidated Green Fluorescent Protein and Its Incorporation in Supported Lipid Bilayers
2005 StandoutNobel
Kinetic resolution of racemic Grignard reagents by nickel-catalyzed asymmetric Grignard cross-coupling
1981
Novel Cationic Lipids Incorporating an Acid-Sensitive Acylhydrazone Linker: Synthesis and Transfection Properties
2004
Chemical Glycoproteomics
2016 StandoutNobel
Works of David Willner being referenced
Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates
1993 Science
(6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicin
1993
New hydrazone derivatives of Adriamycin and their immunoconjugates - a correlation between acid stability and cytotoxicity
1991
Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicin.
1999
Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.
1997
The Ring Expansion Route to Bicyclic Carbonium Ions. II. The Multiple Rearrangement of the exo-2-Norbornylcarbinyl System1a-c
1964
Site‐directed delivery of anthracyclines for treatment of cancer
1995
The Absolute Configurations of Some Simple Norbornane Derivatives. A Test of the “Conformational Asymmetry” Model1a
1961
Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Peptide Linkers: Inhibition of Aggregation by Methoxytriethyleneglycol Chains
2002
Antitumor activity of carcinoma-reactive BR96-doxorubicin conjugate against human carcinomas in athymic mice and rats and syngeneic rat carcinomas in immunocompetent rats.
1997
Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity
2002
Cycloaddition of acetylenes to 7-acylamino-3-azidomethyl-3-cephem-4-carboxylic acids
1972
Synthesis and antitumor activity of the immunoconjugate BR96-Dox
1996
Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Linkers: A Novel Method for Increasing the Potency of Doxorubicin Immunoconjugates
1999
Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models.
1992